SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) and Galderma Pharma S.A. Expand Their Agreement to Include Impetigo; Agreement Increases Potential Milestones to $62 Million Plus Double-Digit Royalties on Future Sales